- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | With first MASH drug due for FDA nod, Ionis says me too with phase 2 data | ||
| 13.03. | Novartis hits the cGAS, taking option to buy IFM unit for $90M upfront | ||
| 13.03. | As Crinetics nears FDA run for growth disease drug, a phase 2 test makes the case for carcinoid syndrome, too | ||
| 13.03. | Mallinckrodt, Silence collab to go quiet, but a phase 2 cardiovascular win speaks loudly for the biotech | ||
| 12.03. | Fortrea sells pair of businesses to private equity firm to become 'pure-play' CRO | ||
| 12.03. | In conversation with Medtronic's Frank Chan, head of its off-again, on-again acute care & monitoring division | ||
| 12.03. | Geron faces uphill battle at FDA meeting, as agency questions benefit-risk profile of imetelstat | ||
| 12.03. | Patient Square Capital aims to roll up NanoString assets with $220M bid | ||
| 12.03. | FDA hands Class I label to Abbott HeartMate LVAD software recall | ||
| 12.03. | To boldly go back: Lilly charts 2nd space trip in 4 months, this time with chronic disease tests | ||
| 12.03. | BMS checks out of next-gen Yervoy pact with CytomX, taking $300M in biobucks with it | ||
| 11.03. | Know Labs posts accuracy data comparing its non-invasive glucose monitor to hospital meters | ||
| 11.03. | BioVie cuts 'most de-risked program,' will seek partners for phase-3 ready ascites program | ||
| 11.03. | After crushing loss last year, Acelyrin rebounds with psoriatic arthritis victory | ||
| 11.03. | FDA hands Class I label to Medtronic cerebrospinal fluid tubing recall | ||
| 11.03. | Sensorion's hearing loss drug reaches target in comeback story after phase 2 failure | ||
| 11.03. | Nurix gets BTK degrader back on track after FDA lifts partial hold | ||
| 11.03. | Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color | ||
| 11.03. | Boehringer boosts schizophrenia strategy with €25M upfront for option on Sosei's GPR52 agonists | ||
| 11.03. | Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial | ||
| 08.03. | Siemens Healthineers unveils Apple Vision Pro app for viewing 3D anatomy | ||
| 08.03. | Roche introduces AI-powered diabetes tracker to predict blood sugar highs and lows | ||
| 08.03. | Kronos sends another 5th of staff to the exits 5 months after last layoffs | ||
| 08.03. | Food allergy biotech DBV is running out of cash, with phase 3 trials underway | ||
| 08.03. | President Biden asks Congress for $12B to fund women's health research |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
